PSP Personal Screen

RNS Number:4432Y
Personal Screening PLC
15 February 2006



                             Personal Screening plc

                    Placing and Admission to Trading on AIM

                             First Day of Dealings







Personal Screening (or "the Company"), a supplier of a range of self-test
medical kits and the UK's leading supplier of CE approved home testing kits for
detecting acute and chronic health and medical conditions, announces that it
shares were admitted to trading on AIM today.



The Company has raised gross funds of #799,500 by way of a placing of 79,500,000
New Ordinary Shares of 0.1p each at 1p per share. At the placing price, Personal
Screening will have a market capitalisation of #1,443,832 on Admission. The
number of Ordinary Shares in issue immediately following Admission is
144,383,198 Ordinary Shares of 0.1p each. The percentage of Enlarged Share
Capital being placed pursuant to the placing is 55.1 %.



The Company's shares have been trading on OFEX since 3 January 2001 and the
Group has been trading in its current form since November 2003 when it acquired
Personal Screening International Limited (formerly Personal Screening Limited).
The Company is seeking admission to AIM in order to take advantage of the
market's wider investor base, greater liquidity and better access to retail and
institutional investors. The proceeds of the fundraising are to provide market
support for its current range of products, to introduce new tests and to develop
new trading relationships with other retail outlets. The Directors of Personal
Screening believe that no other company has a larger range of branded approved
tests.



Commenting, Simon Driscoll, Managing Director, Personal Screening, said:



'A quotation on AIM will raise the Company's profile and enhance credibility.
Personal Screening is about to embark on the next stage of its growth. We have
worked hard to develop the widest range of approved self test medical kits in
the UK and been encouraged by the level of interest expressed in the Group's
products. Our restructured operations and new supply arrangements have reduced
the cost-base significantly. The new infrastructure allows us to support higher
levels of sales with only marginal increases in overhead.



Part of the proceeds of the Placing will be used to retain the services of a
medical PR and marketing company to ensure that a steady news-flow is directed
towards key elements of the consumer media to build brand integrity and
awareness. Key objectives will be to develop new products, to build on
Government initiatives and raise consumer consciousness and, to develop
strategic partnerships aimed at exploring new routes to market.'





SP Angel is broker to the Company and Nabarro Wells is Nominated Advisor.
Michael Scorey, who is currently Non-executive Chairman, will become Executive
Chairman subsequent to the appointment of a new Non-executive Director. Aniz
Visram will join the board as Finance Director with immediate effect.



Placing Statistics



Placing Price                                                                       1 pence
Number of existing Ordinary Shares                                                  64,433,198
Number of New Ordinary Shares being sold pursuant to the Placing                    79,950,000
Percentage of Enlarged Issued Share Capital being Placed                            55.1%
Estimated gross proceeds of the Placing                                             #799,500
Estimated net proceeds of the Placing receivable by the Company                     #595,000
Market capitalisation following the Placing at the Placing Price                    #1,443,832
Ticker Symbol                                                                       PSP





Enquiries



Personal Screening


Michael Scorey                                                                      020 7225 2163
Executive Chairman


Simon Driscoll                                                                      01384 350 222

Managing Director





Financial PR

Binns & Co PR Ltd



Peter Binns                                                                         07768 392 582
Chris Steele                                                                        07979 604 687

Binns & Co PR Ltd
www.binnspr.co.uk





Broker



Phil O'Connell                                                                      020 7422 4300
SP Angel





Nominated Advisors


Keith Smith                                                                         020 7710 7403
Nabarro Wells


Jonathan Naess                                                                      020 7710 7400

Nabarro Wells




                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

MSCILFEIFEIELIR

Grafico Azioni Personal Screening (LSE:PSP)
Storico
Da Giu 2024 a Lug 2024

Grafico Azioni Personal Screening (LSE:PSP)
Storico
Da Lug 2023 a Lug 2024